Sort
261,768 grants matching “gene therapy”
Molecular and Cellular Mechanisms of Experience-Dependent Cortical Processing
$1,042,576Kuan Wang · National Institute Of Mental Health · ZIA · FY2011 · MH
National Gene Vector Biorespository and Coordinating Center at Indiana University
$1,042,555Kenneth G Cornetta · Indiana University Indianapolis · P40 · FY2010 · RR
SPORE in Pancreatic Cancer
$1,042,511James L Abbruzzese · University Of Tx Md Anderson Can Ctr · P20 · FY2007 · CA
Search for the Structural Basis of Biomacromolecular Function and Activity
$1,042,358Yun Xing M Wang · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Genes, substance use, and HIV outcomes in people living with HIV across the US
$1,042,014Heidi M. Crane · University Of Washington · R01 · FY2021 · DA
Polyclonal Tregs to Promote Tolerance in Pediatric Liver Transplant Recipients
$1,041,984Sandy Feng · University Of California, San Francisco · U01 · FY2013 · AI
Host-bacterial interactions determining the spectrum of Mtb transmission
$1,041,944Padmini Salgame · Rutgers Biomedical And Health Sciences · R01 · FY2025 · AI
Project 3: Defining the appropriate context for targeting kinase signaling in combination with androgen receptor blockade to enhance therapeutic response in metastatic prostate cancer
$1,041,837Brett Stewart Carver · Sloan-Kettering Inst Can Research · U54 · FY2017 · CA
Human Connectomes for Low Vision, Blindness, and Sight Restoration
$1,041,828Yonggang Shi · University Of Southern California · U01 · FY2016 · EY
Novel Cannabinoid Receptor Modulators
$1,041,823Malliga Iyer · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2022 · AA
University of California and UT Southwestern D-PDTC
$1,041,580Luis Guillermo Carvajal Carmona · University Of California At Davis · U54 · FY2025 · CA
Candidate selection of a LPAR1 antagonist for therapeutic application in NASH
$1,041,548Fabio Cohen Tucci · Epigen Biosciences, Inc. · R44 · FY2024 · DK
Impact of Celecoxib and Inflammation on Survival in Stage III Colon Cancer
$1,041,509Charles S Fuchs · Yale University · R01 · FY2017 · CA
Project 3:Optimal use of ART in establishing functional cures
$1,041,441Michael David Alpert · Scripps Florida · U19 · FY2021 · AI
Cell Therapy Core
$1,041,313Michael I Nishimura · Loyola University Chicago · P01 · FY2012 · CA
Late Effects of Treatment in Wilms Tumor Survivors and Offspring
$1,041,309Norman E Breslow · Fred Hutchinson Cancer Research Center · R01 · FY2010 · CA
Molecular Biology Of Outer Retina-specific Proteins
$1,041,307Thomas Redmond · National Eye Institute · ZIA · FY2015 · EY
Vascular Delivery of alpha-Sarcoglycan for LGMD2D
$1,041,296Jerry Mendell · Research Inst Nationwide Children'S Hosp · U01 · FY2011 · AR
Molecular Pathogenesis Of JC Virus & Progressive Multifocal Leukoencephalopathy
$1,041,287Eugene O. Major · National Institute Of Neurological Disorders And Stroke · ZIA · FY2010 · NS
A multi-faceted approach to identifying K-Ras synthetic lethal relationships
$1,041,188Kevin Michael Haigis · Beth Israel Deaconess Medical Center · U01 · FY2018 · CA
A multi-faceted approach to identifying K-Ras synthetic lethal relationships
$1,041,188Kevin Michael Haigis · Beth Israel Deaconess Medical Center · U01 · FY2017 · CA
WASHINGTON UNIVERSITY PAUL CALABRESI CAREER DEVELOPMENT AWARD FOR CLINICAL ONCOLO
$1,041,138Ramaswamy Govindan · Washington University · K12 · FY2015 · CA
TEXAS CANCER GENETICS CONSORTIUM
$1,041,093University Of Texas Md Anderson Can Ctr · U24 · FY2000 · CA
Patient-Derived Models of Prostate Cancer for Personalized Medicine
$1,041,019Nora M Navone · University Of Tx Md Anderson Can Ctr · U01 · FY2019 · CA
GrowthDifferentiation Factors in Organogenesis
$1,041,001Alan Perantoni · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA